Uri Yablonka
CIK: 0001608814
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BCLI
BRAINSTORM CELL THERAPEUTICS INC.
DirectorOfficer
Discretionary Trading P&L
Holdings
About Yablonka Uri
Yablonka Uri (SEC CIK 0001608814) files insider reports with the SEC as EVP & Chief Business Officer of BRAINSTORM CELL THERAPEUTICS INC. (BCLI).
Signal8 holds 2 ownership filings by Yablonka Uri, all Form 4s, filed between Jan 3, 2025 and May 29, 2026. Those filings report 3 transactions, from Jan 1, 2025 to Feb 26, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Yablonka Uri's filings is in NEW YORK, NY.
Recent filings by Yablonka Uri
Other insiders filing for BRAINSTORM CELL THERAPEUTICS INC. (BCLI)
- FRENKEL JACOB A, Director
- Pitts Peter Joe, Executive Chairman
- Lebovits Chaim, President & CEO
- Patlis Alla
- ARBEL IRIT, Director
- Bairu Menghisteab, Director